FY 1990: Big Bucks For Big Science

The budget pledges more money for science, but whether this will translate into support for individual scientists remains. WASHINGTON, D.C.--For scientists who depend on funds from NSF and NIH, one important implication of President Reagan's final budget is a new emphasis on raising the size of individual grants. But it's not all good news: The budget, barring radical surgery by Congress, may fund fewer new grants than might be expected. And Reagan's desire to spend more on interdisciplinary c

Written byJeffrey Mervis
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Overall, Reagan's budget once again reflects his support for science. It requests a 14% rise in funding for NSF, 5.3% more for NIH (including a 25% hike in AIDS research), 9% more for the space science and applications portion of the NASA budget, and 14% more for the Department of Energy's basic civilian research program (including $150 million to begin construction of the superconducting supercollider). President Bush is expected to modify portions of Reagan's total $1.15 trillion request, but not in ways that would significantly alter federal spending on basic research.

But the Reagan/Bush figures for the fiscal year that begins October 1 may not translate into more grants to individual investigators. At NSF, for example, much of the increase will be used instead to boost the average size of awards."We need to go up to $110,000 or $120,000 over time," NSF director Erich Bloch says about the size of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies